INTI Insider Trading Activity and SEC Form 4 Filings
INTI insider trading summary
No open-market insider purchases or sales of Inhibitor Therapeutics, Inc. (INTI) have been reported on SEC Form 4 in the past 12 months.
Latest INTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 2, 2019 | Garrison J. Hasara | CFO and Treasurer | Buy | $945 (13,500 @ $0.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.